JAKE PERKINS: Open Payments
NPI 1386288686 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,486 in 179 payments from 36 companies in 2025. Trend: 2023 $3,034 · 2024 $3,686 · 2025 $3,486
Food & beverage: $3,439Education: $47
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 24 | $513 |
| ABBVIE INC. | 36 | $492 |
| Lundbeck LLC | 8 | $226 |
| TG Therapeutics, Inc. | 8 | $177 |
| PFIZER INC. | 16 | $156 |
| Neurelis, Inc. | 8 | $146 |
| Lilly USA, LLC | 12 | $135 |
| Neurocrine BioSciences, Inc. | 4 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $120 |
| Impel Pharmaceuticals LLC | 5 | $114 |
Products named: Zilbrysq, UBRELVY, VYEPTI, QULIPTA, BRIUMVI, VALTOCO, NURTEC ODT, INGREZZA.
Industry payments across CA — which companies pay providers there.
